Upgrade to SI Premium - Free Trial

BioNTech (BNTX) PT Lowered to $94 at Leerink Partners

April 7, 2026 6:21 AM
Leerink Partners analyst Daina Graybosch lowered the price target on BioNTech (NASDAQ: BNTX) to $94.00 (from $113.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change